1. Maurer M. и др. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update // Allergy. 2018. Т. 73, N 8. С. 1575 - 1596.

2. Caballero T. и др. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. // J. Investig. Allergol. Clin. Immunol. 2011. Т. 21, N 6. С. 422 - 441.

3. Cicardi M. и др. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group // Allergy. 2014. Т. 69, N 5. С. 602 - 616.

4. Obtulowicz K. Bradykinin-mediated angioedema // Polish Arch. Intern. Med. 2016. Т. 126, N 1 - 2. С. 76 - 85.

5. Picard C. и др. Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 // J. Clin. Immunol. 2015. Т. 35, N 8. С. 696 - 726.

6. Germenis A.E., Speletas M. The Genetics of Hereditary Angioedema the Iceberg Slowly Emerges // J. Angioedema. 2016. Т. 2, N 1. С. 8 - 17.

7. Germenis A.E., Speletas M. Genetics of Hereditary Angioedema Revisited // Clin. Rev. Allergy Immunol. Clinical Reviews in Allergy & Immunology, 2016. Т. 51, N 2. С. 170 - 182.

8. Santacroce R. и др. The Genetics of Hereditary Angioedema: A Review // J. Clin. Med. 2021. Т. 10, N 9. С. 2023.

9. Davis A., Lu F., Mejia P. C1 inhibitor, a multi-functional serine protease inhibitor // Thromb. Haemost. 2010. Т. 104, N 11. С. 886 - 893.

10. Bork K. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema // Immunotherapy. 2014. Т. 6, N 5. С. 533 - 551.

11. Kaplan A.P., Joseph K. Pathogenesis of Hereditary Angioedema: The Role of the Bradykinin-Forming Cascade // Immunol. Allergy Clin. North Am. Elsevier Inc, 2017. Т. 37, N 3. С. 513 - 525.

12. Caccia S., Suffritti C., Cicardi M. Pathophysiology of Hereditary Angioedema // Pediatr. Allergy. Immunol. Pulmonol. 2014. Т. 27, N 4. С. 159 - 163.

13. Bas M. и др. Nonallergic angioedema: role of bradykinin. // Allergy. 2007. Т. 62, N 8. С. 842 - 856.

14. Levi M., Cohn D.M., Zeerleder S. Hereditary angioedema: Linking complement regulation to the coagulation system // Res. Pract. Thromb. Haemost. 2019. Т. 3, N 1. С. 38 - 43.

15. van Geffen M. и др. Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency // Clin. Exp. Immunol. 2012. Т. 167, N 3. С. 472 - 478.

16. Cicardi M. и др. Novelties in the diagnosis and treatment of angioedema // J. Investig. Allergol. Clin. Immunol. 2016. Т. 26, N 4. С. 212 - 221.

17. Bafunno V. и др. Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema // J. Allergy Clin. Immunol. 2018. Т. 141, N 3. С. 1009 - 1017.

18. Bork K. и др. Hereditary angioedema with a mutation in the plasminogen gene // Allergy. 2018. Т. 73, N 2. С. 442 - 450.

19. Veronez C.L. и др. Genetic Variation of Kallikrein-Kinin System and Related Genes in Patients With Hereditary Angioedema // Front. Med. 2019. Т. 6, N February. С. 1 - 6.

20. Bork K. и др. Guideline: Hereditary angioedema due to C1 inhibitor deficiency: S1 Guideline of the German Society for Angioedema (Deutsche Gesellschaft fur Angio deme, DGA), German Society for Internal Medicine (Deutsche Gesellschaft fur Innere Medizin, DGIM), German S // Allergo J. Int. 2019. Т. 28, N 1. С. 16 - 29.

21. Alonso M.L.O. и др. Hereditary angioedema: a prospective study of a Brazilian single-center cohort // Int. J. Dermatol. 2019. С. ijd.14676.

22. Deroux A. и др. Hereditary angioedema with normal C1 inhibitor and factor XII mutation: a series of 57 patients from the French National Center of Reference for Angioedema // Clin. Exp. Immunol. 2016. Т. 185, N 3. С. 332 - 337.

23. F12-related hereditary angioedema with normal C1Inh.

24. Zuraw B.L. Hereditary angioedema with normal C1 inhibitor: Four types and counting // J. Allergy Clin. Immunol. 2018. Т. 141, N 3. С. 884 - 885.

25. Marcelino-Rodriguez I. и др. Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics // Front. Genet. 2019. Т. 10.

26. Steiner U.C. и др. Hereditary angioedema due to C1 - inhibitor deficiency in Switzerland: clinical characteristics and therapeutic modalities within a cohort study // Orphanet J. Rare Dis. 2016. Т. 11, N 1. С. 43.

27. Bouillet L. и др. Hereditary angioedema with C1 inhibitor deficiency: clinical presentation and quality of life of 193 French patients // Ann. Allergy, Asthma Immunol. American College of Allergy, Asthma & Immunology, 2013. Т. 111, N 4. С. 290 - 294.

28. Bork K. и др. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. // Am. J. Med. 2006. Т. 119, N 3. С. 267 - 274.

29. Bork K., Hardt J., Witzke G. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency // J. Allergy Clin. Immunol. 2012. Т. 130, N 3. С. 692 - 697.

30. Xu Y.-Y. и др. Upper airway edema in 43 patients with hereditary angioedema // Ann. Allergy, Asthma Immunol. 2014. Т. 112, N 6. С. 539 - 544. e1.

31. Martinez-Saguer I., Farkas H. Erythema Marginatum as an Early Symptom of Hereditary Angioedema: Case Report of 2 Newborns // Pediatrics. 2016. Т. 137, N 2. С. e20152411.

32. Zotter Z. и др. The influence of trigger factors on hereditary angioedema due to C1-inhibitor deficiency. // Orphanet J. Rare Dis. 2014. Т. 9, N 44. С. 1 - 6.

33. Hahn J. и др. Angioedema // Dtsch. Aerzteblatt Online. 2017. Т. 114, N 29 - 30. С. 489 - 496.

34. Weldon D. Differential Diagnosis of Angioedema // Immunol. Allergy Clin. North Am. 2006. Т. 26, N 4. С. 603 - 613.

35. Farkas H. Management of upper airway edema caused by hereditary angioedema // Allergy, Asthma Clin. Immunol. 2010. Т. 6, N 19. С. 1 - 8.

36. Misra L., Khurmi N., Trentman T. Angioedema: Classification, management and emerging therapies for the perioperative physician // Indian J. Anaesth. 2016. Т. 60, N 8. С. 534 - 541.

37. Giavina-Bianchi P. и др. Brazilian Guidelines for Hereditary Angioedema Management - 2017 Update Part 1: Definition, Classification and Diagnosis // Clinics. 2018. Т. 73.

38. Gobert D. и др. Angioedemes par deficit acquis en C1-inhibiteur: recommandations du CREAK pour le diagnostic et la prise en charge // La Rev. Medecine Interne. 2020. Т. 41, N 12. С. 838 - 842.

39. Bowen T. и др. 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema // Allergy, Asthma Clin. Immunol. 2010. Т. 6, N 24. С. 1 - 13.

40. Caballero T. и др. Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. // J. Investig. Allergol. Clin. Immunol. 2011. Т. 21, N 5. С. 333 - 347.

41. Agostoni A. и др. Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond // J. Allergy Clin. Immunol. 2004. Т. 114, N 3. С. S51 - S131.

42. Martinez-Saguer I. и др. Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study // Transfusion. 2014. Т. 54, N 6. С. 1552 - 1561.

43. Richards S. и др. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology // Genet. Med. 2015. Т. 17, N 5. С. 405 - 423.

44. Farkas H. и др. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency // Allergy Eur. J. Allergy Clin. Immunol. 2017. Т. 72, N 2. С. 300 - 313.

45. Aabom A. и др. Clinical characteristics and real-life diagnostic approaches in all Danish children with hereditary angioedema // Orphanet J. Rare Dis. 2017. Т. 12, N 1. С. 55.

46. Craig T. и др. WAO Guideline for the Management of Hereditary Angioedema // World Allergy Organ. J. 2012. Т. 5, N 12. С. 182 - 199.

47. Germenis A.E. и др. International Consensus on the Use of Genetics in the Management of Hereditary Angioedema // J. Allergy Clin. Immunol. Pract. 2019.

48. Maurer M. и др. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update // Allergy. 2022.

49. Drouet et all. SERPING1 Variants and C1-INH Biological Function: A Close Relationship With C1-INH-HAE 2022, Front. Allergy 3: 835503.

50. Близнец и др. ДНК-диагностика наследственного ангионевротического отека и клиническое значение вариантов гена SERPING1 / 2018, Медицинская генетика, N 7, стр. 11 - 20.

51. Tarzi M.D. и др. An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio-oedema // Clin. Exp. Immunol. 2007. Т. 149, N 3. С. 513 - 516.

52. Pedrosa M. и др. Complement Study Versus CINH Gene Testing for the Diagnosis of Type I Hereditary Angioedema in Children // J. Clin. Immunol. 2016. Т. 36, N 1. С. 16 - 18.

53. Karim Y. Normal complement C4 values do not exclude hereditary angioedema // J. Clin. Pathol. 2004. Т. 57, N 2. С. 213 - 214.

54. Nielsen E. и др. Activation of the Complement, Coagulation, Fibrinolytic and Kallikrein-Kinin Systems During Attacks of Hereditary Angioedema // Scand. J. Immunol. 1996. Т. 44, N 2. С. 185 - 192.

55. Zanichelli A. и др. Diagnosis, Course, and Management of Angioedema in Patients With Acquired C1-Inhibitor Deficiency // J. Allergy Clin. Immunol. Pract. 2017. Т. 5, N 5. С. 1307 - 1313.

56. Riedl M.A. и др. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data // J. Allergy Clin. Immunol. Pract. Elsevier, 2016. Т. 4, N 5. С. 963 - 971.

57. Wentzel и др. Fresh frozen plasma for on-demand hereditary angioedema treatment in South Africa and Iran. World Allergy Organization Journal (2019) 12(9)

58. Moreno A.S. и др. Coagulation Factor XII Gene Mutation in Brazilian Families with Hereditary Angioedema with Normal C1 Inhibitor // Int. Arch. Allergy Immunol. 2015. Т. 166, N 2. С. 114 - 120.

59. Firinu D. и др. Characterization of patients with angioedema without wheals: The importance of F12 gene screening // Clin. Immunol. 2015. Т. 157, N 2. С. 239 - 248.

60. Aygoren-Pursun E., Bork K. Hereditares Angioodem // Internist (Berl). 2019. Т. 60, N 9. С. 987 - 995.

61. Bork K. и др. Hereditary angioedema cosegregating with a novel kininogen 1 gene mutation changing the N-terminal cleavage site of bradykinin // Allergy. 2019. Т. 74, N 12. С. 2479 - 2481.

62. Patel N. и др. Hereditary Angioedema and Gastrointestinal Complications: An Extensive Review of the Literature // Case Reports Immunol. 2015. Т. 2015. С. 1 - 8.

63. Riguzzi C. и др. Gastrointestinal Manifestations of Hereditary Angioedema Diagnosed by Ultrasound in the Emergency Department // West. J. Emerg. Med. 2014. Т. 15, N 7. С. 816 - 818.

64. Farkas H. и др. Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema // Eur. J. Gastroenterol. Hepatol. 2001. Т. 13, N 10. С. 1225 - 1230.

65. Dinkel H.-P., Maroske J., Schrod L. Sonographic appearances of the abdominal manifestations of hereditary angioedema // Pediatr. Radiol. 2001. Т. 31, N 4. С. 296 - 298.

66. Weller K. и др. The Angioedema Quality of Life Questionnaire (AE-QoL) - assessment of sensitivity to change and minimal clinically important difference // Allergy. 2016. Т. 71, N 8. С. 1203 - 1209.

67. Бодня О.С. и др. Долгосрочная профилактика наследственного ангиоотека в России: резолюция Совета экспертов. 2021. Т. 18, N 3. С. 126 - 130.

68. Weller K. и др. Development and construct validation of the angioedema quality of life questionnaire // Allergy. 2012. Т. 67, N 10. С. 1289 - 1298.

69. Kulthanan K. и др. Angioedema quality of life questionnaire (AE-QoL) - interpretability and sensitivity to change // Health Qual. Life Outcomes. 2019. Т. 17, N 1. С. 160.

70. Манто И.А. и др. Место шкал и опросников в оценке тяжести течения и подборе долгосрочной профилактики у пациентов с наследственным ангиоотеком // Терапевтический архив. 2021. Т. 93, N 12. С. 1498 - 1509.

71. Borum M.L., Ali M.A. Hereditary angioedema: what the gastroenterologist needs to know // Clin. Exp. Gastroenterol. 2014. Т. 20, N 7. С. 435 - 445.

72. Caballero T. и др. International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency // J. Allergy Clin. Immunol. 2012. Т. 129, N 2. С. 308 - 320.

73. Busse P.J. и др. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema // J. Allergy Clin. Immunol. Pract. 2021. Т. 9, N 1. С. 132 - 150. e3.

74. Maurer M. и др. The international WAO/EAACI guideline for the management of hereditary angioedema - the 2017 revision and update // World Allergy Organ. J. 2018. Т. 11. С. 5.

75. Betschel S. и др. The International/Canadian Hereditary Angioedema Guideline // Allergy, Asthma Clin. Immunol. 2019. Т. 15, N 1. С. 72.

76. Farkas H. и др. The efficacy of short-term danazol prophylaxis in hereditary angioedema patients undergoing maxillofacial and dental procedures // J. Oral Maxillofac. Surg. 1999. Т. 57, N 4. С. 404 - 408.

77. Farkas H. и др. Short-term prophylaxis in hereditary angioedema due to deficiency of the C1-inhibitor--a long-term survey. // Allergy. 2012. Т. 67, N 12. С. 1586 - 1593

78. Longhurst H. и др. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor // N. Engl. J. Med. 2017. Т. 376, N 12. С. 1131 - 1140.

79. Bork K., Hardt J. Hereditary Angioedema: Long-Term Treatment with One or More Injections of C1 Inhibitor Concentrate per Week // Int. Arch. Allergy Immunol. 2011. Т. 154, N 1. С. 81 - 88.

80. Craig T. и др. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. // Allergy Rhinol. (Providence). 2017. Т. 8, N 1. С. 13 - 19.

81. Michel Baucher и др. Drug therapies for the long-term prophylaxis for hereditary angioedema attacs / Ottava CADTH, 2019 Dec. (CADTH Technology Rewiew, no 25) https://www.cadth.ca/sites/default/files/hta-he/ob0007-hae-prophylaxis-redacted.pdf

82. Saule C. и др. Benefits of progestin contraception in non-allergic angioedema // Clin. Exp. Allergy. 2013. Т. 43, N 4. С. 475 - 482.

83. Maitrot-Mantelet L. и др. Antigonadotropic progestogens as contraceptive agents in women with contraindication to combined pill // Horm. Mol. Biol. Clin. Investig. 2010. Т. 3, N 3. С. 441 - 447.

84. Bouillet L. и др. Traitements des angioedemes hereditaires: Recommandations du centre de reference national des angioedemes (consensus 2014de Bordeaux) // Press. Medicale. 2015. Т. 44, N 5. С. 526 - 532.

85. Longhurst H.J. Hereditary and other orphan angioedemas: A new prophylactic option at last? // Clin. Exp. Allergy. 2013. Т. 43, N 4. С. 380 - 382.

86. Garcia J.F.B. и др. Use of pdC1-INH concentrate for long-term prophylaxis during pregnancy in hereditary angioedema with normal C1-INH // J. Allergy Clin. Immunol. Pract. 2018. Т. 6, N 4. С. 1406 - 1408.

87. Lumry W.R. и др. Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial // Ann. Allergy, Asthma Immunol. 2011. Т. 107, N 6. С. 529 - 537. e2.

88. Cicardi M. и др. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. // N. Engl. J. Med. 2010. Т. 363, N 6. С. 532 - 541.

89. Craig T.J. и др. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks // J. Allergy Clin. Immunol. 2009. Т. 124, N 4. С. 801 - 808.

90. Lumry W.R. и др. Icatibant for Multiple Hereditary Angioedema Attacks across the Controlled and Open-Label Extension Phases of FAST-3 // Int. Arch. Allergy Immunol. 2015. Т. 168, N 1. С. 44 - 55.

91. Craig T.J. и др. Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks // Ann. Allergy, Asthma Immunol. 2013. Т. 111, N 3. С. 211 - 215.

92. Maurer M. и др. Hereditary Angioedema Attacks Resolve Faster and Are Shorter after Early Icatibant Treatment // PLoS One / под ред. Stover C.M. 2013. Т. 8, N 2. С. e53773.

93. Hernandez Fernandez de Rojas D. и др. Treatment of HAE Attacks in the Icatibant Outcome Survey: An Analysis of Icatibant Self-Administration versus Administration by Health Care Professionals // Int. Arch. Allergy Immunol. 2015. Т. 167, N 1. С. 21 - 28.

94. Kawalec P. и др. Administration of conestat alfa, human C1 esterase inhibitor and icatibant in the treatment of acute angioedema attacks in adults with hereditary angioedema due to C1 esterase inhibitor deficiency. Treatment comparison based on systematic review results // Pneumonol. Alergol. Pol. 2013. Т. 81, N 2. С. 95 - 104.

95. Farkas H. и др. Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema // J. Allergy Clin. Immunol. Pract. Elsevier Inc, 2017. Т. 5, N 6. С. 1671 - 1678. e2.

96. Farkas H. и др. Safety Of Plasma-derived C1-inhibitor Treatment In Pediatric Patients With Hereditary Angioedema Due To C1-inhibitor Deficiency - A Long-term Survey // J. Allergy Clin. Immunol. 2017. Т. 139, N 2. С. AB236.

97. Farkas H., Kohalmi K.V. Icatibant for the treatment of hereditary angioedema with C1-inhibitor deficiency in adolescents and in children aged over 2 years // Expert Rev. Clin. Immunol. 2018. Т. 14, N 6. С. 447 - 460.

98. Busse P. и др. Safety of C1-inhibitor concentrate use for hereditary angioedema in pediatric patients // J. Allergy Clin. Immunol. Pract. American Academy of Allergy, Asthma & Immunology, 2017. Т. 5, N 4. С. 1142 - 1145.

99. Викторова Е.А. и др., Анализ эффективности и безопасности применения патогенетической терапии с целью купирования атак у детей с наследственным ангионевротическим отеком // Педиатрия им. Сперанского Г.Н. 2023 / ТОМ 102 / N 2.

100. Muhlberg H., Ettl N., Magerl M. An analysis of the teaching of intravenous self-administration in patients with hereditary angio-oedema // Clin. Exp. Dermatol. 2016. Т. 41, N 4. С. 366 - 371.

101. Cicardi M. и др. Review of Recent Guidelines and Consensus Statements on Hereditary Angioedema Therapy with Focus on Self-Administration // Int. Arch. Allergy Immunol. 2013. Т. 161, N s1. С. 3 - 9.

102. Aygoren-Pursun E. и др. On demand treatment and home therapy of hereditary angioedema in Germany - the Frankfurt experience // Allergy, Asthma Clin. Immunol. 2010. Т. 6, N 21. С. 1 - 4.

103. Betschel S. и др. Canadian hereditary angioedema guideline // Allergy, Asthma Clin. Immunol. 2014. Т. 10, N 50. С. 1 - 18.

104. Zuraw B.L. и др. Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel // Allergy Asthma Proc. 2012. Т. 33, N 6. С. 145 - 156.

105. Bork K. и др. Hereditary angioedema caused by missense mutations in the factor XII gene: Clinical features, trigger factors, and therapy // J. Allergy Clin. Immunol. 2009. Т. 124, N 1. С. 129 - 134.

106. Bouillet L. и др. Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks. // Ann. Allergy, Asthma Immunol. 2009. Т. 103, N 5. С. 448.

107. Boccon-Gibod I., Bouillet L. Safety and efficacy of icatibant self-administration for acute hereditary angioedema // Clin. Exp. Immunol. 2012. Т. 168, N 3. С. 303 - 307.

108. Pinero-Saavedra M. и др. Hereditary angioedema with F12 mutation // Ann. Allergy, Asthma Immunol. 2016. Т. 117, N 5. С. 520 - 526.

109. Bouillet L. и др. Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant // Immunity, Inflamm. Dis. 2017. Т. 5, N 1. С. 29 - 36.

110. Ohsawa I. и др. Clinical and laboratory characteristics that differentiate hereditary angioedema in 72 patients with angioedema // Allergol. Int. Elsevier Masson SAS, 2014. Т. 63, N 4. С. 595 - 602.

111. Bouillet L. и др. Hereditary angioedema with normal C1 inhibitor: clinical characteristics and treatment response with plasma-derived human C1 inhibitor concentrate (Berinert^(R)) in a French cohort // Eur. J. Dermatology. 2017. Т. 27, N 2. С. 155 - 159.

112. Craig T.J. и др. Treatment response after repeated administration of C1 esterase inhibitor for successive acute hereditary angioedema attacks // Allergy Asthma Proc. 2012. Т. 33, N 4. С. 354 - 361.

113. Pekdemir M. и др. Effective Treatment of Hereditary Angioedema with Fresh Frozen Plasma in an Emergency Department // J. Emerg. Med. 2007. Т. 33, N 2. С. 137 - 139.

114. Prematta M. и др. Fresh frozen plasma for the treatment of hereditary angioedema // Ann. Allergy, Asthma Immunol. 2007. Т. 98, N 4. С. 383 - 388.

115. Pickering R.J. и др. Replacement therapy in Hereditary angioedema // Lancet. 1969. Т. 293, N 7590. С. 326 - 330.

116. Magerl M. и др. Hereditary Angioedema with Normal C1 Inhibitor // Immunol. Allergy Clin. North Am. 2017. Т. 37, N 3. С. 571 - 584.

117. Zanichelli A. и др. Standard care impact on angioedema because of hereditary C1 inhibitor deficiency: a 21-month prospective study in a cohort of 103 patients // Allergy. 2011. Т. 66, N 2. С. 192 - 196.

118. Betschel S. и др. Development of the Hereditary Angioedema Rapid Triage Tool // J. Allergy Clin. Immunol. Pract. 2020. Т. 8, N 1. С. 310 - 317. e3.

119. Bork K. и др. Risk of laryngeal edema and facial swellings after tooth extraction in patients with hereditary angioedema with and without prophylaxis with C1 inhibitor concentrate: a retrospective study // Oral Surgery, Oral Med. Oral Pathol. Oral Radiol. Endodontology. 2011. Т. 112, N 1. С. 58 - 64.120.

120. Aygoren-Pursun E. и др. Risk of angioedema following invasive or surgical procedures in HAE type I and II - the natural history // Allergy. 2013. Т. 68, N 8. С. 1034 - 1039

121. Jurado-Palomo J. и др. Management of dental-oral procedures in patients with hereditary angioedema due to C1 inhibitor deficiency. // J. Investig. Allergol. Clin. Immunol. 2013. Т. 23, N 1. С. 1 - 6.

122. Magerl M. и др. Short-term prophylactic use of C1-inhibitor concentrate in hereditary angioedema: Findings from an international patient registry // Ann. Allergy, Asthma Immunol. The Authors, 2017. Т. 118, N 1. С. 110 - 112.

123. Bouillet L. и др. Disease expression in women with hereditary angioedema // Am. J. Obstet. Gynecol. 2008. Т. 199, N 5. С. 484.e1 - 484.e4

124. Sabharwal G., Craig T. Pediatric hereditary angioedema: an update // F1000Research. 2017. Т. 6, N 0. С. 1205.

125. Peled M. и др. Preoperative prophylaxis for C1 esterase-inhibitor deficiency in patients undergoing oral surgery: a report of three cases. // Quintessence Int. 1997. Т. 28, N 3. С. 169 - 171.

126. Atkinson J.C., Frank M.M. Oral manifestations and dental management of patients with hereditary angioedema. // J. Oral Pathol. Med. 1991. Т. 20, N 3. С. 139 - 142.

127. Banerji A. и др. Effect of Lanadelumab Compared With Placebo on Prevention of Hereditary Angioedema Attacks // JAMA. 2018. Т. 320, N 20. С. 2108.

128. Riedl M.A. и др. An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension. // Clin. Transl. Allergy. 2017. Т. 7. С. 36.

129. Banerji A. и др. Long-term prevention of hereditary angioedema attacks with lanadelumab: The HELP OLE Study // Allergy. 2021.

130. Craig T. и др. Long-Term Outcomes with Subcutaneous C1-Inhibitor Replacement Therapy for Prevention of Hereditary Angioedema Attacks // J. Allergy Clin. Immunol. Pract. 2019. Т. 7, N 6. С. 1793 - 1802. e2.

131. Lumry W.R. и др. Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study // J. Allergy Clin. Immunol. Pract. 2019. Т. 7, N 5. С. 1610 - 1618. e4.

132. Li H.H. и др. Subcutaneous C1-esterase inhibitor to prevent hereditary angioedema attacks: Safety findings from the COMPACT trial // Allergy Asthma Proc. 2018. Т. 39, N 5. С. 365 - 370.

133. Lumry W.R. и др. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema // J. Allergy Clin. Immunol. Pract. 2018. Т. 6, N 5. С. 1733 - 1741. e3.

134. Bork K., Fischer B., Dewald G. Recurrent episodes of skin angioedema and severe attacks of abdominal pain induced by oral contraceptives or hormone replacement therapy // Am. J. Med. 2003. Т. 114, N 4. С. 294 - 298.

135. Gonzalez-Quevedo T. и др. Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency // J. Investig. Allergol. Clin. Immunol. 2016. Т. 26, N 3. С. 161 - 167.

136. Milingos D.S. и др. Hereditary angioedema and pregnancy: successful management of recurrent and frequent attacks of angioedema with C1-inhibitor concentrate, danazol and tranexamic acid - a case report. // Obstet. Med. 2009. Т. 2, N 3. С. 123 - 125.

137. Fox J. и др. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema // Allergy Asthma Proc. 2017. Т. 38, N 3. С. 216 - 221.

138. Wintenberger C. и др. Tranexamic acid as maintenance treatment for non-histaminergic angioedema: analysis of efficacy and safety in 37 patients // Clin. Exp. Immunol. 2014. Т. 178, N 1. С. 112 - 117.

139. Maurer M., Magerl M. Hereditary angioedema: an update on available therapeutic options // JDDG J. der Dtsch. Dermatologischen Gesellschaft. 2010. Т. 8, N 9. С. 663 - 672.

140. Bork K., Bygum A., Hardt J. Benefits and risks of danazol in hereditary angioedema: a long-term survey of 118 patients // Ann. Allergy, Asthma Immunol. 2008. Т. 100, N 2. С. 153 - 161.

141. Fust G. и др. Long-term efficacy of danazol treatment in hereditary angioedema // Eur. J. Clin. Invest. 2011. Т. 41, N 3. С. 256 - 262.

142. Gelfand J.A. и др. Treatment of Hereditary Angioedema with Danazol // N. Engl. J. Med. 1976. Т. 295, N 26. С. 1444 - 1448.

143. Maurer M., Magerl M. Long-term prophylaxis of hereditary angioedema with androgen derivates: a critical appraisal and potential alternatives // J. der Dtsch. Dermatologischen Gesellschaft. 2011. Т. 9, N 2. С. 99 - 107.

144. Craig T. и др. Long-term prophylaxis therapy in patients with hereditary angioedema with C1 inhibitor deficiency // Ann. Allergy, Asthma Immunol. Elsevier Inc., 2018. Т. 121, N 6. С. 673 - 679.

145. Латышева Т.В. и др. Долгосрочная профилактика ангиоотеков у пациентов с НАО // Российский аллергологический журнал. 2019. Т. 16, N 3. С. 75 - 83.

146. Bork K. и др. Treatment for hereditary angioedema with normal C1-INH and specific mutations in the F12 gene (HAE-FXII) // Allergy. 2017. Т. 72, N 2. С. 320 - 324.

147. Belbezier A., Boccon-Gibod I., Bouillet L. Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency // J. Allergy Clin. Immunol. Pract. 2021. Т. 9, N 6. С. 2490 - 2491.

148. Adil Adatia, Bruce Ritchie. Successful use of lanadelumab in a patient with hereditary angioedema with normal C1 inhibitor and negative genetic testing J Allergy Clin Immunol Glob. 2023 May; 2(2).

149. Bork K. и др. Clinical features of genetically characterized types of hereditary angioedema with normal C1 inhibitor: a systematic review of qualitative evidence // Orphanet J. Rare Dis. 2020. Т. 15, N 1. С. 289.

150. Nicole Beard и др. Interventions for the long-term prevention of hereditary angioedema attacks // Cochrane Database Syst Rev 2022 Nov 3; 11(11).

151. Veronez C.L. и др. Hereditary Angioedema with Normal C1 Inhibitor and F12 Mutations in 42 Brazilian Families // J. Allergy Clin. Immunol. Pract. 2018. Т. 6, N 4. С. 1209 - 1216. e8.

152. Gower R.G. и др. Hereditary angioedema caused by c1-esterase inhibitor deficiency: a literature-based analysis and clinical commentary on prophylaxis treatment strategies. // World Allergy Organ. J. 2011. Т. 4, N 2 Suppl. С. S9 - S21.

153. Banerji A., Riedl M. Managing the female patient with hereditary angioedema // Women's Heal. 2016. Т. 12, N 3. С. 351 - 361.

154. Weller K. и др. Development, validation, and initial results of the Angioedema Activity Score // Allergy. 2013. С. n/a-n/a.

155. Moxie GmbH [Электронный ресурс]. URL: https://moxie-gmbh.de/.

156. Weller K. и др. Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema Control // J. Allergy Clin. Immunol. Pract. 2020. Т. 8, N 6. С. 2050 - 2057. e4.